title: Molecular mechanisms of amphetamine actions in Caenorhabditis elegans.
abstract: Amphetamine (AMPH) poses a serious hazard to public health. Defining the molecular targets of AMPH is essential to developing treatments for psychostimulant abuse. AMPH elicits its behavioral effects primarily by increasing extracellular dopamine (DA) levels through the reversal of the DA transporter (DAT) cycle and, as a consequence, altering DA signaling. In Caenorhabditis elegans, an excess of synaptic DA results in a loss of motility in water, termed swimming-induced paralysis (SWIP). Here we demonstrate that AMPH produces SWIP in a time- and dose-dependent manner in wild-type (wt) animals but has a reduced ability to generate SWIP in DAT knock out worms (dat-1). To determine whether D1-like and/or D2-like receptors are involved in AMPH-induced SWIP, we performed experiments in DOP-1 and DOP-4, and DOP-2, and DOP-3 receptor knockout animals, respectively. AMPH administration resulted in a reduced ability to induce SWIP in animals lacking DOP-3, DOP-4, and DOP-2 receptors. In contrast, in worms lacking DOP-1 receptors, AMPH-induced SWIP occurred at wt levels. Using microamperometry on C. elegans DA neurons, we determined that in contrast to wt cells, AMPH failed to promote DA efflux in dat-1 DA neurons. These data suggest that DA efflux is critical to sustaining SWIP behavior by signaling through DOP-3, DOP-4, and DOP-2. In a double mutant lacking both DAT-1 and DOP-1 expression, we found no ability of AMPH to induce SWIP or DA efflux. This result supports the paradigm that DA efflux through C. elegans DAT is required for AMPH-induced behaviors and does not require DOP-1 signaling.
authors.affiliation: Department of Pharmacology, Physiology and Therapeutics, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
authors.forename: Lucia
authors.initials: L
authors.lastname: Carvelli
authors.forename: Dawn S
authors.initials: DS
authors.lastname: Matthies
authors.forename: Aurelio
authors.initials: A
authors.lastname: Galli
mesh_terms: D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D030801:Animals, Genetically Modified; D001522:Behavior, Animal; D017173:Caenorhabditis elegans / Q000187:drug effects* / Q000502:physiology; D004298:Dopamine / Q000378:metabolism; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism
chemical_list: D000662:Amphetamines; D050483:Dopamine Plasma Membrane Transport Proteins; D004298:Dopamine
references.citation: Genetics. 1992 Jul;131(3):609-24
references.pmid: 1321065
references.citation: Brain Res. 1991 Jun 21;552(1):141-52
references.pmid: 1833032
references.citation: Nature. 1995 May 4;375(6526):73-8
references.pmid: 7723846
references.citation: Nature. 1996 Feb 15;379(6566):606-12
references.pmid: 8628395
references.citation: J Neurosci. 1992 Jul;12(7):2439-50
references.pmid: 1319476
references.citation: J Neurosci. 2004 Feb 4;24(5):1217-25
references.pmid: 14762140
references.citation: Parkinsonism Relat Disord. 2001 Jul;7(3):177-183
references.pmid: 11331184
references.citation: Neurosci Lett. 1996 Aug 30;215(1):53-6
references.pmid: 8880752
references.citation: J Neurochem. 1995 Feb;64(2):689-99
references.pmid: 7830062
references.citation: Genes Brain Behav. 2004 Oct;3(5):266-72
references.pmid: 15344920
references.citation: Drug Alcohol Depend. 1995 May;38(2):95-137
references.pmid: 7671769
references.citation: Neuron. 2000 Jun;26(3):619-31
references.pmid: 10896158
references.citation: J Neurosci. 1999 Nov 15;19(22):9831-40
references.pmid: 10559392
references.citation: J Biol Chem. 2003 Apr 4;278(14):12070-7
references.pmid: 12556446
references.citation: J Neurosci. 2000 Oct 1;20(19):7297-306
references.pmid: 11007887
references.citation: Science. 1988 Nov 4;242(4879):715-23
references.pmid: 2903550
references.citation: J Neurosci. 1993 Dec;13(12):5407-17
references.pmid: 8254383
references.citation: Neuron. 1995 Apr;14(4):803-12
references.pmid: 7718242
references.citation: Neurosci Biobehav Rev. 2000 Jan;24(1):125-32
references.pmid: 10654668
references.citation: J Neurochem. 2005 Aug;94(4):1146-57
references.pmid: 16001968
references.citation: J Neurosci. 1998 Mar 15;18(6):1979-86
references.pmid: 9482784
references.citation: Brain Res. 2003 Dec 24;994(2):203-15
references.pmid: 14642646
references.citation: Genetics. 1974 May;77(1):71-94
references.pmid: 4366476
references.citation: Annu Rev Pharmacol Toxicol. 2003;43:521-44
references.pmid: 12415122
references.citation: J Neurosci. 2007 Dec 19;27(51):14216-27
references.pmid: 18094261
references.citation: Neuron. 1995 Jan;14(1):79-89
references.pmid: 7826644
references.citation: J Comp Neurol. 1975 Sep 15;163(2):215-26
references.pmid: 240872
references.citation: Nat Neurosci. 2004 Oct;7(10):1096-103
references.pmid: 15378064
references.citation: Neurosci Lett. 2002 Feb 8;319(1):13-6
references.pmid: 11814642
references.citation: Biochemistry. 1992 Jul 28;31(29):6710-8
references.pmid: 1322169
references.citation: J Neurosci. 2001 Apr 15;21(8):2851-60
references.pmid: 11306637
references.citation: Prog Neurobiol. 2005 Apr;75(6):406-33
references.pmid: 15955613
references.citation: Neuron. 1990 Dec;5(6):797-808
references.pmid: 2268433
references.citation: J Neurosci. 1999 Jan 1;19(1):72-84
references.pmid: 9870940
references.citation: J Pharmacol Exp Ther. 1992 May;261(2):811-8
references.pmid: 1349649
references.citation: J Neurochem. 1993 Feb;60(2):527-35
references.pmid: 8419534
references.citation: Dev Neurosci. 1998;20(1):1-18
references.pmid: 9600386
references.citation: J Neurochem. 2003 Aug;86(4):869-78
references.pmid: 12887685
references.citation: Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):16046-51
references.pmid: 15520385
references.citation: EMBO J. 2004 Jan 28;23(2):473-82
references.pmid: 14739932
references.citation: Physiol Rev. 1998 Jan;78(1):189-225
references.pmid: 9457173
references.citation: J Biol Chem. 1994 Jun 24;269(25):17215-20
references.pmid: 8006030
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9333-8
references.pmid: 16754872
references.citation: J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):482-97
references.pmid: 9276849
references.citation: Cell Motil Cytoskeleton. 1991;20(1):69-78
references.pmid: 1756579